Novus Biologicals全國總代

美國Novus Biologicals公司是一家抗體專業公司，生產用于研究的單克隆和多克隆抗體，包含5萬多種一抗和近1000種二抗，產品涉及神經生物學，細胞凋亡，腫瘤，DNA修復，干細胞標記，信號轉導等多個研究方向。多年的抗體生產服務經驗，使novus得以生物科學發展趨勢，并可隨時為生物科研工作者提供和廣泛的產品。Novus的愿景是通過開發和銷售在前沿科學的*產品來推動科學發現。Novus組織了商業化機制，致力于為生物研究界提供*的生物材料。Novus還持續關注科學趨勢，并為新的研究提供必要的材料。Novus的產品廣泛使用于機構和商業研究，并在推動生物學研究中起著重要的。

Novus Biologicals is a biotech company based in Littleton, Colorado, USA with offices in San Diego, California, Oakville, ON, Canada and the Cambridge Science Park in Cambridge, UK.[1] The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus, like many others companies such as Abcam, Covance, Proteintech Group, EnCor Biotechnology and Millipore Corporation, arose to answer a call for research grade antibodies for the scientific market.Founded by Karen Padgett in 1996, Novus Biologicals has sought to partner with leading scientific researchers and third-party providers to develop an extensive range of more than 180,000 products.[2] The main products are antibodies, proteins, peptides, RNAi, cell lysates, isotype controls, slides, and kits. Padgett is company president and CEO, and has been active both in the academic and local Colorado communities.